The same study, investigated that SMAD7, an antagonist of TGF-β signaling, is significantly reduced in striatal cell lines expressing mHTT and in iPSC derived neural progenitors cells (NPCs), an event that may possibly explain the increase in TGF-β signaling in HD neurons [20]. This evidence concerns the gene SMAD7 and Huntington disease.